CCOC(=O)c1c(N2CCOCC2)[nH]c(=O)c(C(c2c(O)c(C(=O)OCC)c(N3CCOCC3)[nH]c2=O)C(C)C)c1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?